Immunoassay shows DLD’s high expression may reduce T cell-mediated anti-tumor immunity by regulating CD276 and immune checkpoints LAG3 positively and regulating CD8 + T cells’ immune infiltration. This evidence concerns the gene CD8A and neoplasm.